Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial

Human Heredity

Volumn 75, Issue , 2013, Pages 160-174

  McCaffery, Jeanne M ^a   Papandonatos, George D ^b   Huggins, Gordon S ^c   Peter, Inga ^d   Erar, Bahar ^b   Kahn, Steven E ^e   Knowler, William C ^g   Lipkin, Edward W ^f   Kitabchi, Abbas E ^h   Wagenknecht, Lynne E ⁱ   Wing, Rena R ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e 778 CRB   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^h UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Diet; Genetics; Obesity; Type 2 diabetes; Weight loss

Indexed keywords

BILE SALT;

ABCB11 GENE; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT EDUCATION; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RANK GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TNFRSF11A GENE; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; ATP-BINDING CASSETTE TRANSPORTERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; WEIGHT GAIN; WEIGHT LOSS;

EID: 84885005388     PISSN: 00015652     EISSN: 14230062     Source Type: Journal    
DOI: 10.1159/000353181     Document Type: Article

References (68)

1. NHLBI: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6: 51S-210S.
2. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
3. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
4. Diabetes Prevention Program Research Group: The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999; 22: 623-634.
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
6. Wing RR: Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010; 170: 1566-1575.
7. Stunkard AJ, Foch TT, Hrubec Z: A twin study of human obesity. JAMA 1986; 256: 51-54.
8. Maes HH, Neale MC, Eaves LJ: Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997; 27: 325-351.
9. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, et al: Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010; 42: 937-948.
10. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P, et al: Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009; 41: 18-24.
11. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al: Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009; 41: 25-34.
12. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB: Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009; 49: 868-913.
13. McCaffery JM, Papandonatos GD, Bond DS, Lyons MJ, Wing RR: Gene . environment interaction of vigorous exercise and body mass index among male Vietnam-era twins. Am J Clin Nutr 2009; 89: 1011-1018.
14. Lajunen HR, Kaprio J, Rose RJ, Pulkkinen L, Silventoinen K: Genetic and environmental influences on BMI from late childhood to adolescence are modified by parental education. Obesity (Silver Spring) 2012; 20: 583-589.
15. Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, Pasquale LR, Ridker PM, Hunter DJ, Willett WC, Rimm EB, Chasman DI, Hu FB, Qi L: Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med 2012; 367: 1387-1396.
16. Qi Q, Li Y, Chomistek AK, Kang JH, Curhan GC, Pasquale LR, Willett WC, Rimm EB, Hu FB, Qi L: Television watching, leisure time physical activity, and the genetic predisposition in relation to body mass index in women and men. Circulation 2012; 126: 1821-1827.
17. Thomas D: Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010; 11: 259-272.
18. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, et al: Concept, design and implementation of a cardiovascular genecentric 50 k SNP array for large-scale genomic association studies. PLoS One 2008; 3:e3583.
19. Ryan DH, Espeland MA, Foster GD, Haffner SM, Hubbard VS, Johnson KC, Kahn SE, Knowler WC, Yanovski SZ: Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003; 24: 610-628.
20. Bray G, Gregg E, Haffner S, Pi-Sunyer XF, WagenKnecht LE, Walkup M, Wing R: Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006; 3: 202-215.
21. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, et al: Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007; 30: 1374-1383.
22. Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW: Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care 2012; 35: 363-366.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
24. McCaffery JM, Papandonatos GD, Huggins GS, Peter I, Kahn SE, Knowler WC, Hudnall GE, Lipkin EW, Kitabchi AE, Wagenknecht LE, Wing RR: FTO predicts weight regain in the Look AHEAD clinical trial. Int J Obes (Lond) 2013, E-pub ahead of print.
25. TIBCO Software I: TIBCO Spotfire SPLUS 8.2 for Solaris/Linux Users Guide. Seattle, WA, TIBCO Software, Inc, 2010.
26. McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, Cheskin LJ, Balasubramanyam A, Wagenknecht LE, Wing RR: Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr 2012; 95: 1477-1486.
27. Li J, Ji L: Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005; 95: 221-227.
28. Sidak Z: Rectangular confidence region for the means of multivariate normal distributions. J Am Stat Assoc 1967; 62: 626-633.
29. Dabney A, Storey JD: Q-value estimation for false discovery rate control. R package version 1.30.0.
30. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
31. Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC: The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007; 50: 2451-2460.
32. Lindi VI, Uusitupa MI, Lindstrom J, Louheranta A, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Tuomilehto J: Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002; 51: 2581-2586.
33. Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC, Florez JC: Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program. Diabetologia 2008; 51: 2214-2223.
34. Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM, Bray GA, Qi L: FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes 2012; 61: 3005-3011.
35. Stieger B: Recent insights into the function and regulation of the bile salt export pump (ABCB11). Curr Opin Lipidol 2009; 20: 176-181.
36. Jansen PL, Strautnieks SS, Jacquemin E, Hadchouel M, Sokal EM, Hooiveld GJ, Koning JH, De Jager-Krikken A, Kuipers F, Stellaard F, Bijleveld CM, Gouw A, Van Goor H, Thompson RJ, Muller M: Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 1999; 117: 1370-1379.
37. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-238.
38. Noe J, Kullak-Ublick GA, Jochum W, Stieger B, Kerb R, Haberl M, Mullhaupt B, Meier PJ, Pauli-Magnus C: Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. J Hepatol 2005; 43: 536-543.
39. van Mil SW, van der Woerd WL, van der Brugge G, Sturm E, Jansen PL, Bull LN, van den Berg IE, Berger R, Houwen RH, Klomp LW: Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004; 127: 379-384.
40. Chambers JC, Zhang W, Sehmi J, Li X, Wass MN, et al: Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 2011; 43: 1131-1138.
41. Wang R, Salem M, Yousef IM, Tuchweber B, Lam P, Childs SJ, Helgason CD, Ackerley C, Phillips MJ, Ling V: Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci USA 2001; 98: 2011-2016.
42. Henkel AS, Kavesh MH, Kriss MS, Dewey AM, Rinella ME, Green RM: Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice. Gastroenterology 2011; 141: 1404-1411, 1411.e1-e2.
43. Andreotti G, Menashe I, Chen J, Chang SC, Rashid A, Gao YT, Han TQ, Sakoda LC, Chanock S, Rosenberg PS, Hsing AW: Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China. Eur J Epidemiol 2009; 24: 763-774.
44. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, et al: A bivariate genomewide approach to metabolic syndrome: STAMPEED Consortium. Diabetes 2011; 60: 1329-1339.
45. Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, et al: A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 2008; 320: 1085-1088.
46. Gomez-Ambrosi J, Rodriguez A, Catalan V, Fruhbeck G: The bone-adipose axis in obesity and weight loss. Obes Surg 2008; 18: 1134-1143.
47. An JJ, Han DH, Kim DM, Kim SH, Rhee Y, Lee EJ, Lim SK: Expression and regulation of osteoprotegerin in adipose tissue. Yonsei Med J 2007; 48: 765-772.
48. Holecki M, Zahorska-Markiewicz B, Janowska J, Nieszporek T, Wojaczynska-Stanek K, Zak-Golab A, Wiecek A: The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. Obesity (Silver Spring) 2007; 15: 1925-1929.
49. Cheverud JM, Ehrich TH, Hrbek T, Kenney JP, Pletscher LS, Semenkovich CF: Quantitative trait loci for obesity-and diabetes-related traits and their dietary responses to high-fat feeding in LGXSM recombinant inbred mouse strains. Diabetes 2004; 53: 3328-3336.
50. Zhao LJ, Guo YF, Xiong DH, Xiao P, Recker RR, Deng HW: Is a gene important for bone resorption a candidate for obesity? An association and linkage study on the RANK (receptor activator of nuclear factor-kappaB) gene in a large Caucasian sample. Hum Genet 2006; 120: 561-570.
51. Hohjoh H, Takasu M, Shishikura K, Takahashi Y, Honda Y, Tokunaga K: Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome. Neurogenetics 2003; 4: 151-153.
52. Cappuccio FP, Taggart FM, Kandala NB, Currie A, Peile E, Stranges S, Miller MA: Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008; 31: 619-626.
53. Jessen N, An D, Lihn AS, Nygren J, Hirshman MF, Thorell A, Goodyear LJ: Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 2011; 301:E164-E171.
54. Meyre D, Farge M, Lecoeur C, Proenca C, Durand E, Allegaert F, Tichet J, Marre M, Balkau B, Weill J, Delplanque J, Froguel P: R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet 2008; 17: 1798-1802.
55. Stone S, Abkevich V, Russell DL, Riley R, Timms K, Tran T, Trem D, Frank D, Jammulapati S, Neff CD, Iliev D, Gress R, He G, Frech GC, Adams TD, Skolnick MH, Lanchbury JS, Gutin A, Hunt SC, Shattuck D: TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet 2006; 15: 2709-2720.
56. Looker HC, Knowler WC, Hanson RL: Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 2001; 24: 1917-1922.
57. Divoux A, Clement K: Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes Rev 2011; 12:e494-e503.
58. Christiaens V, Lijnen HR: Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue. Arch Physiol Biochem 2006; 112: 254-259.
59. de Meijer VE, Sverdlov DY, Le HD, Popov Y, Puder M: Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity. Hepatol Res 2012; 42: 601-610.
60. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111-122.
61. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, Khokha R: Abnormal TNF activity in Timp3-/-mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 2004; 36: 969-977.
62. Rosen ED, MacDougald OA: Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 2006; 7: 885-896.
63. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA, Sicard A, Rome S, Benis A, Zucker JD, Vidal H, Laville M, Barsh GS, Basdevant A, Stich V, Cancello R, Langin D: Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-1669.
64. Ii H, Hatakeyama S, Tsutsumi K, Sato T, Akiba S: Group IVA phospholipase A2 is associated with the storage of lipids in adipose tissue and liver. Prostaglandins Other Lipid Mediat 2008; 86: 12-17.
65. Mancuso DJ, Sims HF, Yang K, Kiebish MA, Su X, Jenkins CM, Guan S, Moon SH, Pietka T, Nassir F, Schappe T, Moore K, Han X, Abumrad NA, Gross RW: Genetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation. J Biol Chem 2010; 285: 36495-36510.
66. Song H, Wohltmann M, Bao S, Ladenson JH, Semenkovich CF, Turk J: Mice deficient in group VIB phospholipase A2 (iPLA2gamma) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet. Am J Physiol Endocrinol Metab 2010; 298:E1097-E1114.
67. Lijnen HR, Maquoi E, Hansen LB, Van Hoef B, Frederix L, Collen D: Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 2002; 22: 374-379.
68. Shi C, Sakuma M, Mooroka T, Liscoe A, Gao H, Croce KJ, Sharma A, Kaplan D, Greaves DR, Wang Y, Simon DI: Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 2008; 112: 4699-4711.